Central Nervous System Tuberculosis: Neurosurgical Implications

Status: draft · Last updated 2026-11-18 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • CNS TB = meningitis, mass lesions and spine. A negative Mantoux (positive in only 19%) doesn't exclude TBM .
  • Grade predicts outcome (Palur I–IV):
    • mortality 20% → 100% from grade I to IV in the original series ;
    • but 45% of grade IV patients still did well after shunting in a later series .
  • Hydrocephalus: ETV and shunt perform similarly in children (65% vs 62% success in a randomized trial; no difference on meta-analysis) .
  • Stroke is common: 72% at admission, and a quarter more within a month, especially under age 3 and with hydrocephalus .
  • Dexamethasone lowers mortality (adults and adolescents) . Thalidomide was associated with response in complicated mass lesions and optochiasmatic arachnoiditis (uncontrolled cohort) .
  • Tuberculomas can enlarge paradoxically on treatment.
    • Persistent enhancement isn't failure .
    • Operate for mass effect from giant tuberculomas , and for diagnostic doubt or abscess (see caveats).
  • Pott disease in children: posterior-only surgery works about as well as combined approaches, with less blood loss .

Landmark papers

  • Thwaites et al., N Engl J Med 2004: a randomized trial of adjunctive dexamethasone in 545 patients with TBM (aged over 14). It reduced mortality (RR 0.69) but not severe disability .
  • Palur et al., J Neurosurg 1991: the clinical grading (I–IV) and grade-based shunting protocol for TBM hydrocephalus. Grade on admission was the only predictor of outcome .
  • Aranha et al., Asian J Neurosurg 2018: a randomized trial of ETV vs shunt in 52 children with TBM hydrocephalus, with success 65.4% vs 61.5% .

Tuberculosis of the nervous system takes three main forms:

Treatment is medical first: antituberculous therapy plus adjunctive anti-inflammatory drugs. The neurosurgeon is called for:

Jason S. Hauptman, MD, PhD© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure from Hauptman's High Yield Thoughts in Pediatric Neurosurgery (pedsneurosurg.org). Do not copy, reproduce, redistribute or adapt without written permission.https://www.pedsneurosurg.org/hy-peds-ns:cns_tuberculosis:aa8735517bd03600© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure; please do not copy, reproduce or redistribute without written permission.Midsagittal brain with thick basal exudate in the suprasellar and prepontine cisterns encasing vessels, hydrocephalus, and a coronal inset with basal ganglia infarcts; tuberculoma on T1 with contrast (ring) and T2 (dark core with edema), and a giant tuberculoma with midline shift; and Pott disease with anterior vertebral destruction across a disc, a cold abscess, kyphosis and cord compression(A) BASAL MENINGITISthick basal exudatevessels encased, narrowedhydrocephalusbasal ganglia infarcts(B) TUBERCULOMAT1 + contrast: ringT2: dark core, edemagiant tuberculoma: mass effect,midline shift(C) POTT DISEASE (SAGITTAL, ANTERIOR LEFT)anterior body destructionacross the discparaspinal cold abscessepidural pus and debriscompress the cordkyphosis (gibbus)cord
CNS tuberculosis. (a) Basal exudate in the suprasellar and prepontine cisterns encasing the circle of Willis, causing communicating or obstructive hydrocephalus, vasculitis and basal ganglia infarcts. (b) Tuberculoma: a ring-enhancing lesion with a T2-hypointense core and surrounding edema; a giant tuberculoma with mass effect. (c) Pott disease: anterior vertebral body destruction across a disc, paraspinal cold abscess, kyphosis and cord compression. Not to scale.

Tuberculous meningitis in children

Hydrocephalus in TBM

Details are in Management of Hydrocephalus in Bacterial and Viral Meningitis.

Tuberculomas and tuberculous abscesses

Spinal tuberculosis (Pott disease)

Related topics

References

  1. Güneş A, Uluca Ü, Aktar F, et al. Clinical, radiological and laboratory findings in 185 children with tuberculous meningitis at a single centre and relationship with the stage of the disease. Ital J Pediatr 2015;41:75. doi:10.1186/s13052-015-0186-7. PMID 26467304. verified
  2. Palur R, Rajshekhar V, Chandy MJ, et al. Shunt surgery for hydrocephalus in tuberculous meningitis: a long-term follow-up study. J Neurosurg 1991;74(1):64–69. doi:10.3171/jns.1991.74.1.0064. PMID 1984509. verified
  3. Solomons RS, Nieuwoudt ST, Seddon JA, van Toorn R. Risk factors for ischemic stroke in children with tuberculous meningitis. Childs Nerv Syst 2021;37(8):2625–2634. doi:10.1007/s00381-021-05163-2. PMID 33856542. verified
  4. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004;351(17):1741–1751. doi:10.1056/NEJMoa040573. PMID 15496623. verified
  5. van Toorn R, Solomons RS, Seddon JA, Schoeman JF. Thalidomide use for complicated central nervous system tuberculosis in children: insights from an observational cohort. Clin Infect Dis 2021;72(5):e136–e145. doi:10.1093/cid/ciaa1826. PMID 33283220. verified
  6. Srikantha U, Morab JV, Sastry S, et al. Outcome of ventriculoperitoneal shunt placement in grade IV tubercular meningitis with hydrocephalus: a retrospective analysis in 95 patients. J Neurosurg Pediatr 2009;4(2):176–183. doi:10.3171/2009.3.PEDS08308. PMID 19645554. verified
  7. Aranha A, Choudhary A, Bhaskar S, Gupta LN. A randomized study comparing endoscopic third ventriculostomy versus ventriculoperitoneal shunt in the management of hydrocephalus due to tuberculous meningitis. Asian J Neurosurg 2018;13(4):1140–1147. doi:10.4103/ajns.AJNS_107_18. PMID 30459883. verified
  8. Fagundes W, Ahmed AR, Silva YP, et al. Endoscopic third ventriculostomy versus ventriculoperitoneal shunt for treating pediatric tuberculous meningitis hydrocephalus: a systematic review and meta-analysis. J Neurosurg Pediatr 2025;36(3):296–303. doi:10.3171/2025.2.PEDS24441. PMID 40479834. verified
  9. Marais S, Van Toorn R, Chow FC, et al. Management of intracranial tuberculous mass lesions: how long should we treat for? Wellcome Open Res 2019;4:158. doi:10.12688/wellcomeopenres.15501.3. PMID 32047859. verified
  10. Swamy SBG, Jaikumar V, Nagaraj NM, et al. Intracranial giant tuberculoma: a 7-year institutional experience and literature review. Clin Neurol Neurosurg 2023;225:107593. doi:10.1016/j.clineuro.2023.107593. PMID 36701938. verified
  11. Upadhyaya GK, Sami A, Patralekh MK, et al. Surgical management of paediatric thoracolumbar tuberculosis by a combination of anterior and posterior versus posterior only approach: a systematic review and meta-analysis. Global Spine J 2023;13(1):188–196. doi:10.1177/21925682221090478. PMID 35426770. verified

Verification (2026-11-18):

Caveats: